This activity is designed to meet the educational needs of physicians and other clinicians who treat patients with chronic rhinosinusitis with nasal polyps, including specialists (allergists, immunologists, ENTs) and other health care providers who may treat CRSwNP patients.
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic condition that negatively impacts patients’ quality of life and while CRSwNP pathogenesis is poorly understood, type 2 inflammation has been identified as a major driver for most CRSwNP pathophysiology. Increased understanding has resulted in a new class of medical therapy and targeted biologics to address existing unmet medical needs. As such, it is important for clinicians to understand the rationale behind these new treatments and how best to integrate targeted therapies with existing treatment options.
In this roundtable discussion, expert faculty in CRSwNP offer valuable discussions regarding treatment indications, efficacy, and side effects. Improving learners’ knowledge of type 2 inflammation and immunomodulating therapies as well as improving their competence relating to selection of interventions, individualizing CRSwNP treatments, and optimizing patient outcomes.
Upon completion of this activity, participants should be better able to: